SL
Stevard LLC’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-5,011
| Closed | -$271K | – | 29 |
|
|
2024
Q2 | $271K | Sell |
5,011
-396
| -7% | -$21.4K | 0.23% | 50 |
|
|
2024
Q1 | $369K | Buy |
5,407
+121
| +2% | +$8.25K | 0.33% | 39 |
|
|
2023
Q4 | $331K | Buy |
+5,286
| New | +$331K | 0.33% | 40 |
|
|
2023
Q3 | – | Sell |
-4,356
| Closed | -$245K | – | 45 |
|
|
2023
Q2 | $245K | Sell |
4,356
-1,362
| -24% | -$76.5K | 0.23% | 42 |
|
|
2023
Q1 | $259K | Hold |
5,718
| – | – | 0.24% | 44 |
|
|
2022
Q4 | $232K | Hold |
5,718
| – | – | 0.2% | 44 |
|
|
2022
Q3 | $374K | Buy |
+5,718
| New | +$374K | 0.35% | 38 |
|
|
2022
Q1 | $359K | Sell |
5,718
-969
| -14% | -$60.8K | 0.28% | 42 |
|
|
2021
Q4 | $507K | Sell |
6,687
-1,350
| -17% | -$102K | 0.36% | 36 |
|
|
2021
Q3 | $900K | Buy |
8,037
+94
| +1% | +$10.5K | 0.71% | 23 |
|
|
2021
Q2 | $1.29M | Buy |
7,943
+42
| +0.5% | +$6.8K | 0.99% | 22 |
|
|
2021
Q1 | $963K | Sell |
7,901
-604
| -7% | -$73.6K | 0.79% | 22 |
|
|
2020
Q4 | $1.3M | Sell |
8,505
-3,243
| -28% | -$496K | 0.44% | 30 |
|
|
2020
Q3 | $983K | Buy |
11,748
+2,320
| +25% | +$194K | 0.41% | 38 |
|
|
2020
Q2 | $693K | Buy |
+9,428
| New | +$693K | 0.35% | 41 |
|